Healthcare & Life Sciences
Weekly Roundup
Weekly Brief — Healthcare & Life Sciences
Weekly Brief - Healthcare Policy & Pharmaceuticals - 22nd September, 2026
Ministry of Health and Family Welfare launches the 7th National Formulary of India, rolls out the Biovigilance Programme, and expands national patient safety networks.
Key Statistics
| 8th Globally | 1,150+ | 653 Drugs |
|---|---|---|
| India's ranking in contributions to the WHO patient safety database, up from 123rd | Active Adverse Drug Reaction (ADR) reporting centres operational nationwide | Total drugs profiled in the newly released 7th Edition of the NFI (2026) |
Weekly Executive Summary
- Launch of NFI 2026: Union MoS Smt. Anupriya Patel launched the 7th Edition of the National Formulary of India (NFI) and its digital portal to guide rational clinical prescribing (Ref).
- Biovigilance Programme Approval: The Government approved the Biovigilance Programme of India, led by the Indian Pharmacopoeia Commission (IPC), to monitor safety issues in organ/tissue transplantation (Ref).
- Digital & Mobile Health Tools: Unveiled the ADR-PvPI 2.0 Mobile App for iOS and…
Download Full Intelligence Brief (PDF)
Sign in to your PolicyIndex account to download the complete executive-ready PDF report including all policy exhibits, data tables, and strategic recommendations.
Log In to Download PDF Brief →